Coronary Artery Disease-Reporting and Data System (CAD-RADS): strengths and limitations.


Journal

Clinical radiology
ISSN: 1365-229X
Titre abrégé: Clin Radiol
Pays: England
ID NLM: 1306016

Informations de publication

Date de publication:
06 2019
Historique:
received: 01 04 2018
revised: 01 11 2018
accepted: 16 01 2019
pubmed: 16 2 2019
medline: 26 3 2020
entrez: 16 2 2019
Statut: ppublish

Résumé

A new standardised reporting system was introduced recently for coronary computed tomography (CT) angiography interpretation called CAD-RADS (Coronary Artery Disease-Reporting and Data System). Like any other new reporting platform, CAD-RADS has both advantages and disadvantages. Consistency in reporting, better clarity of communication, and more streamlined clinical recommendations are the major strengths of CAD-RADS. It has many limitations such as misinterpretation of CT angiography findings inherent to any CT angiography examination and unique disadvantages like misclassification of abnormalities, potential to misguide the referring physicians by suggesting management based on a single score. In addition, CAD-RADS does not include the details on location and extent of disease in the coronary arteries, coronary anomalies and other cardiac and extra cardiac findings.

Identifiants

pubmed: 30765109
pii: S0009-9260(19)30043-1
doi: 10.1016/j.crad.2019.01.003
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

411-417

Informations de copyright

Copyright © 2019 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Auteurs

S Ramanathan (S)

Department of Radiology, Al-Wakra Hospital, Hamad Medical Corporation, PO Box: 82228, Doha, Qatar; Department of Radiology, Weil Cornell Medical College, Doha, Qatar. Electronic address: drrmsubbu@gmail.com.

M Al Heidous (M)

Department of Radiology, Al-Wakra Hospital, Hamad Medical Corporation, PO Box: 82228, Doha, Qatar.

M Alkuwari (M)

Department of Radiology, Heart Hospital, Hamad Medical Corporation, PO Box: 82228, Doha, Qatar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH